Dibotermin alfa Completed Phase 2 Trials for Fracture Bone Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00384852A Study of rhBMP-2/CPM in Closed Fractures of the Humerus
NCT00384358Feasibility And Safety Study Of rhBMP-2/CPM For Hip Fractures